PROSTATE CANCER RESEARCH

Registered charity 1156027 · accounts filings on the Charity Commission register · also known as PROSTATE CANCER RESEARCH CENTRE, PROSTATE CANCER RESEARCH TRUST

Prostate Cancer Research aims to save lives and improve the quality of life for all those affected by prostate cancer through funding research and empowering patients.

Objects

THE PROMOTION OF MEDICAL AND SCIENTIFIC RESEARCH INTO THE CAUSES AND TREATMENT OF CANCER AND RELATED DISEASES AND DISSEMINATION OF THE USEFUL RESULTS THEREOF.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Registered contact address: Camden, London, England (from the postcode on the register)

Latest income
£7.5m
Latest spending
£6.7m
Registered
2014
Accounts read
FY2026

Financial health, per its FY2026 accounts

The accounts state that the charity achieved a healthy surplus with total income increasing by 45% to £7.5 million. Free unrestricted reserves rose to £1.53 million, which the trustees note is progress towards but still below their stated policy target of £1.7 million. The charity reports adequate resources to continue as a going concern with a strengthened liquidity position.

Automated summary of the FY2026 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Highest-paid employee band: £120,001 - £130,000 — above the 90th percentile for charities its size (median £70k)
“Between £120,001 - £130,000 1 -”
Per its FY2026 accounts as filed with the Charity Commission.
Fundraising cost ratio: 20.5% of fundraised income, as disclosed
“The cost of raising funds was equivalent to 20.5% of total income (2025: 21.0%), broadly stable year on year.”
Per its FY2026 accounts as filed with the Charity Commission.
Trading subsidiary: Prostate Progress Limited
“During the year the charity incorporated a trading company in England and Wales owning 100% of the shareholding. The subsidiary undertaking, Prostate Progress Limited, with £1 share capital has been dormant at the year end.” — page 46
Per its FY2026 accounts as filed with the Charity Commission.

Accounts audited by Moore Kingston Smith LLP. Discloses 4 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/03/2026

  • Volunteers: 150
  • Employees paid over £60,000: 13 (£60,001–£70,000: 5; £70,001–£80,000: 2; £80,001–£90,000: 3; £90,001–£100,000: 1; £100,001–£110,000: 1; £120,001–£130,000: 1)
  • Has a trading subsidiary
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/03/2025

  • Volunteers: 150
  • Employees paid over £60,000: 9 (£60,001–£70,000: 3; £70,001–£80,000: 3; £80,001–£90,000: 1; £90,001–£100,000: 1; £110,001–£120,000: 1)
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/03/2024

  • Volunteers: 150
  • Government income: £525,466 — grants £525,466 (1); 11% of the £4,907,018 total gross income on the same return
  • Employees paid over £60,000: 8 (£60,001–£70,000: 5; £70,001–£80,000: 1; £90,001–£100,000: 1; £110,001–£120,000: 1)
  • Grant-making is its main activity

Source: this charity’s annual returns on the Charity Commission register.

Annual return filing dates (Charity Commission record)

Of its last 5 annual returns with a recorded received date, 1 was received after the due date: year ending 31/03/2024 (received 27/03/2025, 55 days after the 31/01/2025 due date).

Due and received dates as recorded in the Commission’s annual-return data; the data does not say whether an extension was agreed. Source: this charity’s annual returns on the Charity Commission register.

Public fundraising profile: JustGiving — Prostate Cancer Research (matched by registered charity number).

Public profiles (found on the charity’s own website): facebook · instagram

Structured financials (annual return, FY ending 31/03/2026)

Total income
£7.5m
Total spending
£6.7m
Cost of raising funds
£1.5m
Reserves (reported)
£2.3m
Employees
43

Reported reserves equal ~4.2 months of spending — below the median for charities its size (median 4.7 months; benchmarks).

Per its annual return, cost of raising funds: 20.5% of total income — in the top quarter for charities its size (median 5.3%) (benchmarks).

Register events

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2026£7.5m£6.7m
31/03/2025£5.2m£6.1m
31/03/2024£4.9m£4.1m
31/03/2023£3.0m£3.5m
31/03/2022£2.7m£2.6m

Common questions

Is PROSTATE CANCER RESEARCH financially healthy?

Per its FY2026 accounts: The accounts state that the charity achieved a healthy surplus with total income increasing by 45% to £7.5 million. Free unrestricted reserves rose to £1.53 million, which the trustees note is progress towards but still below their stated policy target of £1.7 million. The charity reports adequate resources to continue as a going concern with a strengthened liquidity position. Its FY2026 accounts were audited by Moore Kingston Smith LLP.

What does the highest-paid employee of PROSTATE CANCER RESEARCH earn?

Per its FY2026 accounts, the highest-paid employee was in the £120,001 - £130,000 band.

Who funds PROSTATE CANCER RESEARCH?

Funders whose own accounts filings name PROSTATE CANCER RESEARCH as a grant recipient include BREAST CANCER NOW, PHILIP KING CHARITABLE TRUST, DAVID LISTER CHARITABLE TRUST, PETER STORMONTH DARLING CHARITABLE TRUST, THE WILL CHARITABLE TRUST.

Known funders

Grants to this charity found in funders’ own accounts filings.

FunderYearAmountPurpose (as stated by the funder)
BREAST CANCER NOWFY2024£300kResearch grant
PHILIP KING CHARITABLE TRUSTFY2025£30kGrant towards immunotherapy research project
DAVID LISTER CHARITABLE TRUSTFY2021£16k
PETER STORMONTH DARLING CHARITABLE TRUSTFY2025£13kCharitable donations
THE WILL CHARITABLE TRUSTFY2025£10kCare of Cancer Patients
THE CADOGAN CHARITYFY2023£10kmedical research
THE AMELIA CHADWICK TRUSTFY2021£8k
THE INMAN CHARITYFY2023£7kMedical - Research
THE INMAN CHARITYFY2025£5kMedical - Research
THE WILLIAM ALLEN YOUNG CHARITABLE TRUSTFY2025£5k
THE LAWSON TRUST CIOFY2023£5k
THE SAMUEL STOREY FAMILY CHARITABLE TRUSTFY2021£5k
THE LAWSON TRUST CIOFY2022£5k
THE CHARLES AND ELSIE SYKES TRUSTFY2025Unverified read£5kResearch Project at the Centre for Cancer, Newcastle University. Aiming to develop a blood test which can screen for aggressive prostate cancer.
SCHRODER CHARITY TRUSTFY2021£4k
MISSES BARRIE CHARITABLE TRUSTFY2022£4k
MISSES BARRIE CHARITABLE TRUSTFY2026£4k
MISSES BARRIE CHARITABLE TRUSTFY2025£3k
G M MORRISON CHARITABLE TRUSTFY2024£3k
G M MORRISON CHARITABLE TRUSTFY2025£3k
THE WILLIAM ALLEN YOUNG CHARITABLE TRUSTFY2024£3k
FRAZER TRUSTFY2022£2k
THE FIELDROSE CHARITABLE TRUSTFY2021£2k
FRAZER TRUSTFY2023£2kChildren
FRAZER TRUSTFY2025£2kMedical and other research
THE AMELIA CHADWICK TRUSTFY2022£2k
FRAZER TRUSTFY2021£2kMedical and other research
FRAZER TRUSTFY2024£2kMedical and other research
THE OAKDALE TRUSTFY2024£2k
THE EDGAR E LAWLEY FOUNDATIONFY2023£2k
G M MORRISON CHARITABLE TRUSTFY2022£1k
G M MORRISON CHARITABLE TRUSTFY2023£1k
CHAPMAN CHARITABLE TRUSTFY2023£1k
SIR SAMUEL SCOTT OF YEWS TRUSTFY2024£1k
THE OAKDALE TRUSTFY2026£1k
THE ASTOR FOUNDATIONFY2023£1k
THE IAN ASKEW CHARITABLE TRUSTFY2024£1k
SIR SAMUEL SCOTT OF YEWS TRUSTFY2021£1k
THE CHARLES LITTLEWOOD HILL TRUSTFY2025£1k
MISSES BARRIE CHARITABLE TRUSTFY2023£1k
THE IAN ASKEW CHARITABLE TRUSTFY2023£1k
THE CHANDRIS FOUNDATIONFY2021£500Cancer Relief Charities
THE CHANDRIS FOUNDATIONFY2022£500Cancer Relief Charities
THE MICHAEL AND ANNA WIX CHARITABLE TRUSTFY2026£200
THE SAMUEL STOREY FAMILY CHARITABLE TRUSTFY2022Unverified read£150
THE SAMUEL STOREY FAMILY CHARITABLE TRUSTFY2023£130
THE JONATHAN TOWLER FOUNDATIONFY2024amount not stated
THE JONATHAN TOWLER FOUNDATIONFY2023amount not stated
Beaulieu, Exbury and East Boldre, Parochial Church CouncilFY2022amount not statedRemittances to Charities
THE HOSPITAL SATURDAY FUNDFY2021amount not statedresearch into improving radiotherapy for prostate cancer

Grants marked “Unverified read” were flagged by automated checks as possibly misread from the funder’s filed accounts. They are listed, but left out of the totals, counts and funder relationships this site computes.

Government & lottery funding

Grants to this charity published as open data by government and lottery funders (360Giving).

FunderDateAmountPurpose
The National Lottery Community Fund18/12/2024£496kEmpowering People with Prostate Cancer - Phase 2

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with PROSTATE CANCER UK.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
PROSTATE CANCER RESEARCH£7.5m£120,001 - £130,000—unclear20.5%no doubt
PROSTATE CANCER UK FY2025£45.5m——above—no doubt
THE PROSTATE PROJECT FY2025£493k—0unclear—no doubt
PROST8 UK FY2025£93k—0unclear—no doubt
NATIONAL CANCER RESEARCH INSTITUTE FY2022£1.6m——above—no doubt
CANCER RESEARCH WALES FY2026£5.9m——unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.